Access To Medicines Impacted In Iran Following Tightening Of U.S. Sanctions

New York Times: Iranians Fear Medicine Shortages as U.S. Tightens Sanctions
“…Anxieties over the availability of medicine are mounting in Iran with the reimposition this month of sanctions by the United States after President Trump withdrew from the nuclear deal. Harsh banking restrictions and the threat of secondary sanctions for companies doing business with Iran have made it nearly impossible for foreign pharmaceutical companies to continue working in the country. Trump administration officials say that the sanctions will not affect trade in humanitarian items, but many are skeptical…” (Tabrizy, 11/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.